Pregnancy, Abdominal
Conditions
Keywords
pregnancy, fetal monitoring, fetal oximetry, fetal heart rate, pulse oximetry, near infrared spectroscopy
Brief summary
Three non-invasive, trans-abdominal fetal oximetry probes will be tested on pregnant human subjects, in order to obtain fetal heart rate. We want to determine if this device can accurately measure a baby's oxygen level when placed on your abdomen. Current technology to measure a baby's oxygen levels requires a probe to be inserted into the vagina.
Detailed description
The study subject will have a brief trans-abdominal ultrasound examination. 3 trans-abdominal fetal oximetry probes will be tested for 5 minutes per probe. No probes will be placed into the vagina. It is anticipated that 6 months will be required to recruit, consent and study 25 participants.
Interventions
Administration of Fetal Oximetry Probe on 36 weeks or greater pregnant women
Sponsors
Study design
Eligibility
Inclusion criteria
* Greater than 36 weeks pregnant * Singleton fetus
Exclusion criteria
* Prisoners
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Fetal Photoplethysmogram | 6 months | The primary outcome measure will be if a fetal photoplethysmogram is obtained in the time domain that correlates to the fetal heart rate. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Fetal Heart Rate | 6 months | The secondary endpoint will be if fetal heart rate can be obtained in the frequency domain that correlates to a fetal heart rate obtained by Doppler. |
Countries
United States